Intrastriatal B-cell administration limits infarct size after stroke in B-cell deficient mice

Metabolic Brain Disease

Volumn 27, Issue 4, 2012, Pages 487-493

  Chen, Yingxin ^a   Bodhankar, Sheetal ^a,b   Murphy, Stephanie J ^a   Vandenbark, Arthur A ^a,b,c   Alkayed, Nabil J ^a   Offner, Halina ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

MT mice; Experimental stroke; Intrastriatal transfer; Regulatory B cells

Indexed keywords

CD19 ANTIGEN; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL MIGRATION; CONTROLLED STUDY; CORPUS STRIATUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HEMISPHERE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; REPERFUSION; STEREOTACTIC PROCEDURE;

ANIMALS; ANTIGENS, CD19; B-LYMPHOCYTES, REGULATORY; CELL SEPARATION; CELL TRANSPLANTATION; CEREBELLAR CORTEX; CEREBRAL INFARCTION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; LASER-DOPPLER FLOWMETRY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE CEREBRAL ARTERY; NEOSTRIATUM; STEREOTAXIC TECHNIQUES; STROKE;

MUS;

EID: 84871453759     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-012-9317-7     Document Type: Article

References (20)

1. Ajmo CT, Vernon DO, Collier L, Hall AA, Garbuzova-Davis S, Willing A, Pennypacker KR (2008) The spleen contributes to stroke-induced neurodegeneration. J Neurosci Res 86(10):2227-2234
2. Akiyoshi K, Ren X, Dziennis S, Vandenbark AA, Herson PS, Hurn PD, Offner H (2011) Regulatory B-cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci 31:8556-8563
3. Campanella M, Sciorati C, Tarozzo G, Beltramo M (2002) Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 22(2):586-592
4. Carter NA, Vasconcellos R, Rosser EC, Tulone C, Munoz-Suano A, Kamanaka M, Ehrenstein MR, Flavell RA, Mauri C (2011) Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 186:5569-5579
5. de Bilbao FDA, Moll T, Garcia-Gabay I, Vallet P, Langhans W, Giannakopoulos P (2009) In vivo over-expression of interleukin-10 increases resistance to focal brain ischemia in mice. J Neurochem 110:12-22
6. DiLillo DJ, Matsushita T, Tedder TF (2010) B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 1183:38-57
7. Frenkel D, Huang Z, Maron R, Koldzic DN, Moskowitz MA, Weiner HL (2005) Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci 233:125-132
8. Gee JM, Kalil A, Shea C, Becker KJ (2007) Lymphocytes: potential mediators of postischemic injury and neuroprotection. Stroke 38:783-788
9. Grilli M, Barbieri I, Basudev H, Brusa R, Casati C, Lozza G, Ongini E (2000) Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci 12:2265-2272
10. Hurn PD, Subramanian S, Parker SM, Afentoulis ME, Kaler LJ, Vandenbark AA, Offner H (2007) T-And B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cerebral Blood Flow & Metab 27:1798-1805
11. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nature Medicine 15(2):192-199
12. Mann MK, Maresz K, Shriver LP, Tan Y, Dittel BN (2007) B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol 178:3447-3456
13. Matsushita T, Horikawa M, Iwata Y, Tedder TF (2010) Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol 185:2240-2252
14. Offner H, Hurn PD (2012) A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke. Transl Stroke Res In press
15. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD (2006a) Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cerebral Blood Flow & Metab 26:654-665
16. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A, Vandenbark AA, Hurn PD (2006b) Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 176:6523-6531
17. Planas AM, Gorina R, Chamorro A (2006) Signalling pathways mediating inflammatory responses in brain ischaemia. Biochem Soc Trans 34:1267-1270
18. Yanaba K, Bouazis J-D, Haas KM, Poe JC, Fujimoto M, Tedder TF (2008) A regulatory B cell subset with a unique CD1dhiCD5+ phenotye controls T cell-dependent inflammatory responses. Immunity 28:639-650
19. Yilmaz G, Arumugam TV, Stokes KY, Granger DN (2006) Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113(17):2105-2112
20. Zhu W, Wang L, Zhang L, Palmateer JM, Libal NL, Hurn PD, Herson PS, Murphy SJ (2010) Isoflurane preconditioning neuroprotection in experimental focal stroke is androgen-dependent in male mice. Neuroscience 169(2):758-769